ARTICLE | Company News
RedPath sales and marketing update
March 3, 2014 8:00 AM UTC
RedPath entered into a contract with preferred provider network MultiPlan Inc. (New York, N.Y.) to cover RedPath's PathFinder TG molecular diagnostic assay for pancreatic cancer. RedPath said the dea...